When will Oura officially announce an IPO?
Short Answer
1. Executive Verdict
- Oura's executive team includes C-suite hires with IPO experience.
- The broader health tech IPO market is currently facing significant challenges.
- Oura's key venture capital investors have no immediate pressure for liquidity.
- Oura projects significant revenue growth, aiming for $2 billion by 2026.
- Recent job postings indicate Oura is preparing for public company requirements.
Who Wins and Why
| Outcome | Market | Model | Why |
|---|---|---|---|
| Before Jul 1, 2026 | 8.0% | 5.4% | Research does not highlight strong supporting evidence. |
| Before Oct 1, 2026 | 9.0% | 6.0% | Research does not highlight strong supporting evidence. |
| Before Jan 1, 2027 | 23.0% | 15.5% | Research does not highlight strong supporting evidence. |
| Before Apr 1, 2027 | 24.0% | 16.2% | Research does not highlight strong supporting evidence. |
| Before Jul 1, 2027 | 28.0% | 19.0% | Research does not highlight strong supporting evidence. |
2. Market Behavior & Price Dynamics
Historical Price (Probability)
3. Market Data
Contract Snapshot
For the "Before Jan 1, 2028" market, a "Yes" resolution is triggered if Oura Health Oy officially confirms an IPO before January 1, 2028. Confirmation occurs if the SEC declares their Form S-1 effective, the IPO is priced, or a securities exchange assigns a ticker, as reported by major financial news outlets. If an IPO is not confirmed by December 31, 2027, 11:59 PM EST, the market resolves "No." The market will resolve immediately upon confirmation, even if actual trading begins after January 1, 2028.
Available Contracts
Market options and current pricing
| Outcome bucket | Yes (price) | No (price) | Last trade probability |
|---|---|---|---|
| Before Jul 1, 2026 | $0.08 | $1.00 | 8% |
| Before Oct 1, 2026 | $0.14 | $0.95 | 9% |
| Before Jan 1, 2027 | $0.19 | $0.90 | 23% |
| Before Apr 1, 2027 | $0.23 | $0.86 | 24% |
| Before Jul 1, 2027 | $0.28 | $0.81 | 28% |
| Before Oct 1, 2027 | $0.35 | $0.74 | 35% |
| Before Jan 1, 2028 | $0.40 | $0.69 | 41% |
Market Discussion
Limited public discussion available for this market.
4. Who Are Oura's Recent C-Suite Hires and Their IPO Experience?
| New Chief Financial Officer | Sean Brecker (formerly CFO of Headspace) [^] |
|---|---|
| New Chief Legal Officer & Corporate Secretary | Avonte Campinha-Bacote (formerly Associate General Counsel at Lyft during its IPO) [^] |
| Lead Underwriters Engaged for Oura IPO | No reports of Oura engaging lead underwriters like Goldman Sachs or Morgan Stanley [1-9] [^] |
5. How Are Health Tech IPOs Performing Amidst Market Volatility?
| Renaissance IPO ETF Q1 2026 Performance | Volatility significantly weighed on performance [^] |
|---|---|
| Whoop Market Status | Private company, not publicly traded [^] |
| Oura Health IPO Talks | Reportedly in talks to launch an IPO [^] |
6. Are Oura Investors Under Pressure for a Liquidity Event?
| Forerunner Fund V Age | Approximately 6 years old [^] |
|---|---|
| Lifeline Ventures Latest Funds | Fund V closed 2021, Fund VI launched 2023 [^] |
| MSD Capital (DFO Management) Structure | Family office, not subject to typical VC fund lifecycle pressures [^] |
7. What Are Oura's Revenue Projections and Hardware Dependencies?
| CEO's 2026 Revenue Projection | Close to $2 billion in sales [^] |
|---|---|
| Another 2026 Revenue Projection | $900 million [^] |
| Earlier Revenue Milestone | $1 billion year [^] |
8. Is Oura Preparing for an IPO Based on Recent Hiring?
| Financial Reporting Role | Manager, Global Financial Reporting [^] |
|---|---|
| Accounting Management | Senior Accounting Manager [^] |
| IPO Discussions | Interviewing banks for IPO this year [^] |
9. What Could Change the Odds
Key Catalysts
Key Dates & Catalysts
- Expiration: April 08, 2026
- Closes: January 01, 2028
10. Decision-Flipping Events
- Trigger: Catalyst analysis unavailable.
12. Historical Resolutions
Historical Resolutions: 1 markets in this series
Outcomes: 0 resolved YES, 1 resolved NO
Recent resolutions:
- KXIPOOURA-26APR01: NO (Apr 01, 2026)
Get Real-Time Research Updates
Sign up for early access to live reports, historical data, and AI-powered market insights delivered to your inbox.